Office of Cardiology, Hematology, Endocrinology and Nephrology - Division of Non-Malignant Hematology (DNH)
The Division of Non-Malignant Hematology (DNH) regulates and reviews Investigational New Drug (IND) applications and marketing applications for drug and biologic products for the treatment of non-malignant hematology. Contact Us
Contact Us
Mailing Address:
Food and Drug Administration
Center for Drug Evaluation and Research
Division of Non-Malignant Hematology
10903 New Hampshire Avenue, Silver Spring, MD 20993
Building 22, Suite 4177
Phone: (301) 796-2240
Fax: (301) 796-9838
Resources
- Office of Cardiology, Hematology, Endocrinology and Nephrology
- Office of New Drugs
- CDER Offices and Divisions
- Reorganization of the Office of New Drugs with Corresponding Changes to the Office of Translational Sciences and the Office of Pharmaceutical Quality